A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse

Kamini E. Kuchinad, Heidi E Hutton, Anne K. Monroe, Garrick Anderson, Richard D Moore, Geetanjali Chander

Research output: Contribution to journalArticle

Abstract

Background: Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse. Methods: We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved. Results: Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care. Conclusions: PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.

Original languageEnglish (US)
Article number2032
JournalBMC Research Notes
Volume9
Issue number1
DOIs
StatePublished - Apr 22 2016

Fingerprint

HIV
Pharmaceutical Preparations
Continuity of Patient Care
Testing
Interviews
Ceremonial Behavior
Therapeutics
HIV Infections
HIV-1
Appointments and Schedules
Psychology
Morbidity
Mortality

Keywords

  • Adherence
  • ART
  • HIV
  • HIV care continuum
  • Substance use

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse. / Kuchinad, Kamini E.; Hutton, Heidi E; Monroe, Anne K.; Anderson, Garrick; Moore, Richard D; Chander, Geetanjali.

In: BMC Research Notes, Vol. 9, No. 1, 2032, 22.04.2016.

Research output: Contribution to journalArticle

@article{d87c1e6134a14551b6f5be18c0fafbc5,
title = "A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse",
abstract = "Background: Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse. Methods: We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved. Results: Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care. Conclusions: PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.",
keywords = "Adherence, ART, HIV, HIV care continuum, Substance use",
author = "Kuchinad, {Kamini E.} and Hutton, {Heidi E} and Monroe, {Anne K.} and Garrick Anderson and Moore, {Richard D} and Geetanjali Chander",
year = "2016",
month = "4",
day = "22",
doi = "10.1186/s13104-016-2032-4",
language = "English (US)",
volume = "9",
journal = "BMC Research Notes",
issn = "1756-0500",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse

AU - Kuchinad, Kamini E.

AU - Hutton, Heidi E

AU - Monroe, Anne K.

AU - Anderson, Garrick

AU - Moore, Richard D

AU - Chander, Geetanjali

PY - 2016/4/22

Y1 - 2016/4/22

N2 - Background: Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse. Methods: We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved. Results: Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care. Conclusions: PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.

AB - Background: Persons living with HIV (PLWH) and substance use/misuse experience significant barriers to engagement in HIV care at every step of the HIV care continuum including: (1) HIV testing and diagnosis (2) linkage to clinical care (3) retention in care pre-antiretroviral therapy (ART) (4) ART initiation and adherence (5) viral suppression. We qualitatively explored the facilitators of and barriers to participation in the HIV care continuum among PLWH with substance use/misuse. Methods: We performed semi-structured in-depth interviews with 34 PLWH in care with recent substance use. The transcripts were analyzed in an iterative process using an editing style analysis. Interviews were conducted until thematic saturation was achieved. Results: Participants attributed an escalation in drug use at the time of diagnosis to denial of their disease and the belief that their death was inevitable and cited this as a barrier to treatment entry. In contrast, participants reported that experiencing adverse physical effects of uncontrolled HIV infection motivated them to enroll in care. Reported barriers to retention and adherence to care included forgetting medications and appointments because of drug use, prioritizing drug use over HIV treatment and side effects associated with medications. Participants described that progression of illness, development of a medication taking ritual and a positive provider-patient relationship all facilitated engagement and reengagement in care. Conclusions: PLWH with substance use engaged in care describe barriers to and facilitators of optimal engagement related to and distinct from substance use. Greater understanding of the biologic, psychological and social factors that promote and impair engagement in care can inform interventions and reduce the increased morbidity and mortality experienced by PLWH with substance use.

KW - Adherence

KW - ART

KW - HIV

KW - HIV care continuum

KW - Substance use

UR - http://www.scopus.com/inward/record.url?scp=84966280601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966280601&partnerID=8YFLogxK

U2 - 10.1186/s13104-016-2032-4

DO - 10.1186/s13104-016-2032-4

M3 - Article

C2 - 27103162

AN - SCOPUS:84966280601

VL - 9

JO - BMC Research Notes

JF - BMC Research Notes

SN - 1756-0500

IS - 1

M1 - 2032

ER -